Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIRx Bio

Date Submitted: Oct 19, 2022
Date Accepted: Jul 1, 2024

The final, peer-reviewed published version of this preprint can be found here:

In-Silico Works Using an Improved Hovorka Equations Model and Clinical Works on the Control of Blood Glucose Levels in People With Type 1 Diabetes: Comparison Study

Som AM, Sohadi NAM, Nor NSM, Ali SA, Ahmad MA

In-Silico Works Using an Improved Hovorka Equations Model and Clinical Works on the Control of Blood Glucose Levels in People With Type 1 Diabetes: Comparison Study

JMIRx Bio 2024;2:e43662

DOI: 10.2196/43662

In-silico works using Improved Hovorka Equations Model and Clinical Works on the Control of Blood Glucose Level in People with Type 1 Diabetes: A Comparison Study

  • Ayub Md Som; 
  • Nur Amanina Mohd Sohadi; 
  • Noor Shafina Mohd Nor; 
  • Sherif Abdulbari Ali; 
  • Mohd Aizad Ahmad

ABSTRACT

Background:

Hovorka model is one of the diabetic models which is widely used in the artificial pancreas device (APD) also known as closed loop system, meant for people with type 1 diabetes (T1D). Previous workers had modified some equations in the sub-sections of the Hovorka model, which is also known as improved Hovorka equations, in regulating the blood glucose level (BGL) within normoglycemic range (4.0 to 7.0 mmol/L).

Objective:

The improved Hovorka equations have, however, not been tested yet in terms of its usability to regulate and control the BGL in safe range for two or more people with T1D. This study aims to simulate their BGL with meal disturbances for 24 hours using the improved Hovorka equations.

Methods:

Data for people with T1D were obtained from Clinic 1, Clinical Training Centre (CTC), UiTM Medical Specialist Centre, Sungai Buloh, Selangor. Data collected include gender, age, body weight, mealtimes, meal amount, and duration. Three patients whose ages range from 11 to 14 years old were selected. All patients consumed three meals daily: breakfast, lunch, and dinner. The simulation (in-silico work) was done using MATLAB software, and the BGL profile from both in-silico and clinical works were compared and analysed.

Results:

It was revealed that the BGLs for all three people with T1D were far better in the in-silico work compared to the clinical work. The BGL for patient 1 was able to achieve normoglycaemia 73% of the time in the in-silico work. Meanwhile, patient 2 managed to stay in the normoglycemic range for 85% of the time in the in-silico work compared to clinical work, which was merely 31%. For Patient 3, the time duration spent in the normoglycemic range was only 16% in the in-silico work compared to none as in the clinical work. The p-values obtained in the study were less than 0.05, indicating that the in-silico work using the improved Hovorka equations was acceptable for predicting the BGL for people with T1D.

Conclusions:

It can be concluded that the improved Hovorka equations are reliable in simulating the meal disturbances effect on BGL and increasing people in T1D times9 duration in the normoglycemic range compared to the clinical work. Clinical Trial: This project was approved by the UiTM Research Ethics Committee with their official approval letter reference no: 600-TNCPI (5/1/6) dated 29 October 20I9.


 Citation

Please cite as:

Som AM, Sohadi NAM, Nor NSM, Ali SA, Ahmad MA

In-Silico Works Using an Improved Hovorka Equations Model and Clinical Works on the Control of Blood Glucose Levels in People With Type 1 Diabetes: Comparison Study

JMIRx Bio 2024;2:e43662

DOI: 10.2196/43662

PDF not available

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.